Investigating LXR as a therapeutic target in triple negative breast cancer.

Samantha A. Hutchinson(University of Leeds)

White Rose eTheses Online (University of Leeds, The University of Sheffield, University of York)

January 1, 2020

Cited by 0

Related Papers

Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer

|Oncogene|2021|37

Phytosterols Inhibit Side-Chain Oxysterol Mediated Activation of LXR in Breast Cancer Cells

|International Journal of Molecular Sciences|2019|25

ER-Negative Breast Cancer Is Highly Responsive to Cholesterol Metabolite Signalling

|Nutrients|2019|17

Liver x receptor alpha drives chemoresistance in response to side-chain hydroxycholesterols in triple negative breast cancer

|bioRxiv (Cold Spring Harbor Laboratory)|2020|4